Does smoking cessation with varenicline worsen vascular endothelial function?

OBJECTIVES: A meta-analysis suggested that the use of varenicline, which is a partial agonist of nicotinic acetylcholine receptors and is effective in smoking cessation, increases the risk of cardiovascular events within 52 weeks of starting treatment. Defining these events as occurring during drug...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Umeda, Akira, Kato, Toru, Yamane, Tateki, Yano, Heiichi, Ieiri, Tamio, Miyagawa, Kazuya, Takeda, Hiroshi, Okada, Yasumasa
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2013
Pynciau:
Smoking and Tobacco
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693419/
https://ncbi.nlm.nih.gov/pubmed/23794597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-003052
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg